Electrochemistry for vaccine synthesis and tumor destruction

Title:

Electrochemistry for Vaccine Synthesis and Tumor Destruction

Tech ID: 

2023-009

Status: 

Active 

Category:

Biomedical Electrochemical Technology

Executive Statement:

A novel electrochemical approach that targets viral genetic material and tumor cells by flowing ionizing current to selectively damage and inactivate harmful biological structures.

Description:

This technology utilizes electrochemical cells to flow ionizing currents through aqueous solutions containing dissolved salts, enabling charged ions to traverse viral interiors and cancer cells. By preferentially damaging the DNA and RNA inside viruses while preserving their protein coats, high-quality vaccines are produced. Similarly, electrodes applied directly to tumors deliver currents that selectively destroy cancerous cells by exploiting the higher conductivity of their interiors compared to surrounding membranes.

Key Advantages:

• Selective targeting of viral and cancerous genetic material without extensive damage to surrounding structures
• Utilizes common salts and simple electrochemical methods for efficient treatment
• Potentially scalable for both vaccine production and tumor therapy
• Non-invasive approach for tumor destruction when using externally applied electrodes
• Minimizes chemical reagents or complex biological manipulation

Problems Solved:

• Effective inactivation of viruses for vaccine development without damaging antigenic protein coats
• Destruction of tumor cells through localized electrical treatment
• Reduction of side effects compared to chemical or radiation treatments
• Provides a controllable and targeted method for altering pathogenic and cancerous cells
• Overcomes difficulties in penetrating viral and cellular interiors using traditional methods

Marketing Opportunity:

• Production of high-quality vaccines through controlled viral inactivation
• Electrochemical tumor ablation therapies in clinical oncology
• Development of novel antiviral treatment devices
• Biomedical research tools for studying viral and cellular electrochemical properties
• Potential integration in point-of-care medical devices for rapid infection control and cancer treatment

Inventors: 

• Michael Pravica